Cardiac amyloidosis
Would you like to receive a message when there is new research about cardiac amyloidosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you'll receive a notification as soon as new research on Cardiac Amyloidosis is available. View what Premium costs.
Publications and studies (1417)
- Trends in incidence and clinical outcome of non-ST elevation myocardial infarction in patients with amyloidosis in the United States, 2010-2020. (2023/10/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical and Cardiovascular Magnetic Resonance Imaging Features of Cardiac Amyloidosis. (2023/10/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal. (2023/10/12) ♡
- Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction. (2023/10/10) ♡
- Postdevelopment Performance and Validation of the Artificial Intelligence-Enhanced Electrocardiogram for Detection of Cardiac Amyloidosis. (2023/10/01) ♡
- Clinical characterization and outcomes of a cohort of colombian patients with AL Amyloidosis. (2023/09/30) ♡
- Direct Oral Anticoagulants in Patients With Cardiac Amyloidosis: A Systematic Review and Meta-Analysis. (2023/09/22) ♡
- Quantification of myocardial extracellular volume without blood sampling. (2023/09/15) ♡
- Targeted Therapeutics for Transthyretin Amyloid Cardiomyopathy. (2023/09/01) ♡
- Position statement on the non-invasive diagnosis of patients with ATTR cardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners. (2023/09/01) ♡
- SPECT/CT SUV-based metrics: A promising diagnostic tool in classifying patients with suspected transthyretin cardiac amyloidosis among the different Perugini grades? (2023/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A narrative review and expert recommendations on the assessment of the clinical manifestations, follow-up, and management of post-OLT patients with ATTRv amyloidosis. (2023/08/24) ♡
- Effect of Defibrillator on All-Cause Mortality in Patients With Cardiac Amyloidosis. (2023/08/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive Reduction in Left Ventricular Mass on Serial Cardiac Magnetic Resonance Imaging in a 67-year-old Male Patient With AL-Amyloidosis. (2023/08/19) ♡
- Macrophage Phagocytes Amyloid Fibrils in Giant Cell Myocarditis. (2023/08/01) ♡
- Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT/CT and semiquantitative planar parameters. (2023/08/01) ♡
- Diagnostic value of heart-to-mediastinum ratio in (99m)Tc-pyrophospate SPECT/CT for transthyretin cardiac amyloidosis. (2023/08/01) ♡
- Prospective Screening for Transthyretin Cardiac Amyloidosis in Spinal Stenosis Surgery Patients: Results of the CASS Study. (2023/08/01) ♡
- Initial report of percutaneous left atrial appendage closure in hemodialysis patients with atrial fibrillation and high risk of bleeding in Japan. (2023/07/01) ♡
- Classification of patients with cardiac amyloidosis using machine learning models on Italian electronic clinical health records. (2023/07/01) ♡
- Cardiac amyloidosis remains significantly underdiagnosed in patients undergoing TAVR: analysis of National Inpatient Sample. (2023/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A comprehensive overview of AL amyloidosis disease characteristics accumulated over two decades at a single referral center in Korea. (2023/05/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multimodality imaging for diagnosis of subclinical hereditary transthyretin cardiac amyloidosis. (2023/04/01) ♡
- Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis. (2023/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama. (2023/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epidemiology, Mechanisms, and Management of Atrial Fibrillation in Cardiac Amyloidosis. (2023/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnostic and Prognostic Value of Non-late Gadolinium Enhancement Cardiac Magnetic Resonance Parameters in Cardiac Amyloidosis. (2023/04/01) ♡
- Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis. (2023/04/01) ♡
- Prognostic value of left ventricular global constructive work in patients with cardiac amyloidosis. (2023/03/01) ♡
- Ethnic/racial differences in risk factors and clinical outcomes among patients with amyloidosis. (2023/03/01) ♡
- Prevalence of Orthopedic Manifestations in Patients With Cardiac Amyloidosis With a Focus on Shoulder Pathologies. (2023/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evolving epidemiology of transthyretin amyloid cardiomyopathy due to increased recognition in women. (2023/03/01) ♡
- Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM Criteria. (2023/03/01) ♡
- A Comprehensive Multidisciplinary Diagnostic Algorithm for the Early and Efficient Detection of Amyloidosis. (2023/03/01) ♡
- A Review of Current and Evolving Imaging Techniques in Cardiac Amyloidosis. (2023/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current role of imaging techniques in cardiac amyloidosis. (2023/02/10) ♡
- In-hospital mortality in amyloid light chain amyloidosis: analysis of the Premier Healthcare Database. (2023/02/01) ♡
- Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen. (2023/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. (99m)Tc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis. (2023/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Starting sacubitril-valsartan is safe in patients with transthyretin cardiac amyloidosis and impaired ejection fraction. (2023/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Implications of Extra-cardiac Disease in Patient Selection for Heart Transplantation: Considerations in Cardiac Amyloidosis. (2023/01/31) ♡
- Pro-inflammatory cytokine secretion induced by amyloid transthyretin in human cardiac fibroblasts. (2023/01/29) ♡
- Inotersen to Treat Polyneuropathy Associated with Hereditary Transthyretin (hATTR) Amyloidosis. (2023/01/28) ♡
- Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis. (2023/01/24) ♡
- Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience. (2023/01/19) ♡
- Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis. (2023/01/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Wild-Type Transthyretin Amyloid Cardiomyopathy: The Gordian-Knot of Novel Therapeutic Regimens. (2023/01/01) ♡
- Serial (99m)Technetium Pyrophosphate Scintigraphy and Multimodality Assessments After Different Doses of Tafamidis for Variant Transthyretin Cardiac Amyloidosis. (2023/01/01) ♡
- Clinical profile of patients with cardiac amyloidosis in India. (2023/01/01) ♡
- Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study? (2023/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.